208 results
Page 3 of 11
8-K
EX-10.1
xny6iw803d
20 Jan 22
GeoVax Announces $10 Million Private Placement
4:30pm
8-K
EX-99.1
v5nweuvsfff2
12 Nov 21
GeoVax Reports 2021 Third Quarter Financial Results
1:37pm
424B3
4y6mwi795zofi gw86
12 Nov 21
Prospectus supplement
8:03am
8-K
EX-10.1
bmceo5l1i9 7zavzmwx
10 Nov 21
GeoVax and City of Hope Announce Agreement to
4:41pm
8-K
EX-99.1
3c9g elgcfy32dzbmv2
10 Nov 21
GeoVax and City of Hope Announce Agreement to
4:41pm
8-K
EX-99.1
4hp0g5kt2crmd8l
29 Sep 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
eg1wg4 xb06s976haq
29 Sep 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
omn 0znwr
11 Aug 21
GeoVax Reports 2021 Second Quarter Financial Results
4:30pm
8-K
EX-99.1
igtlqusyi6kr2
7 May 21
GeoVax Reports 2021 First Quarter Financial Results
1:05pm
POS AM
2m6utf dqmtwuadoca
24 Mar 21
Prospectus update (post-effective amendment)
9:17am
8-K
EX-99.1
3slc80ld2copcd
23 Mar 21
GeoVax Reports 2020 Year-End Financial Results
4:35pm
8-K
EX-10.1
7ecf4
11 Feb 21
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
9:21am
8-K
EX-1.01
foph trvvw5a7y7
11 Feb 21
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
9:21am
424B5
in333xei5i2v
11 Feb 21
Prospectus supplement for primary offering
9:17am
8-K
EX-10.1
u4ki72cok6
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-99.1
3431yhjbas 7p915
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm